3.07
Precedente Chiudi:
$3.11
Aprire:
$3.1
Volume 24 ore:
32,055
Relative Volume:
0.39
Capitalizzazione di mercato:
$42.45M
Reddito:
-
Utile/perdita netta:
$-10.31M
Rapporto P/E:
-3.987
EPS:
-0.77
Flusso di cassa netto:
$-12.65M
1 W Prestazione:
-3.76%
1M Prestazione:
+1.49%
6M Prestazione:
+1.15%
1 anno Prestazione:
-2.07%
Grace Therapeutics Inc Stock (GRCE) Company Profile
Nome
Grace Therapeutics Inc
Settore
Industria
Telefono
609-322-1602
Indirizzo
103 CARNEGIE CENTER, PRINCETON
Confronta GRCE con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
GRCE
Grace Therapeutics Inc
|
3.07 | 47.19M | 0 | -10.31M | -12.65M | -0.77 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.58 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
629.53 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.96 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
837.52 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
184.25 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Grace Therapeutics Inc Stock (GRCE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-02 | Iniziato | TD Cowen | Buy |
| 2020-09-01 | Downgrade | Oppenheimer | Outperform → Perform |
| 2020-07-06 | Aggiornamento | B. Riley FBR | Neutral → Buy |
| 2020-01-13 | Downgrade | B. Riley FBR | Buy → Neutral |
| 2019-08-29 | Iniziato | B. Riley FBR | Buy |
| 2019-07-18 | Iniziato | Oppenheimer | Outperform |
| 2019-06-26 | Iniziato | H.C. Wainwright | Buy |
Mostra tutto
Grace Therapeutics Inc Borsa (GRCE) Ultime notizie
Can Grace Therapeutics Inc. stock rebound after recent weaknessRate Hike & Breakout Confirmation Alerts - newser.com
Why Grace Therapeutics Inc. stock could rally in 2025Weekly Risk Report & Weekly Top Gainers Trade List - newser.com
Published on: 2025-11-04 02:49:13 - newser.com
Will Grace Therapeutics Inc. stock outperform value stocksWeekly Trade Analysis & Consistent Growth Stock Picks - newser.com
Why Grace Therapeutics Inc. stock remains on watchlistsJuly 2025 Rallies & Daily Chart Pattern Signals - newser.com
Grace Therapeutics Inc. stock outlook for YEAR2025 Price Momentum & Fast Gain Stock Trading Tips - newser.com
Using RSI to spot recovery in Grace Therapeutics Inc.Market Sentiment Review & Safe Capital Preservation Plans - newser.com
Will Grace Therapeutics Inc. stock outperform Nasdaq indexMarket Trend Review & Low Drawdown Trading Techniques - newser.com
Is Grace Therapeutics Inc. forming a bottoming basePortfolio Return Report & AI Powered Market Entry Ideas - newser.com
Can Grace Therapeutics Inc. stock resist market sell offsInsider Selling & Reliable Breakout Forecasts - newser.com
Is Grace Therapeutics Inc. stock a safe haven assetJuly 2025 Drop Watch & Accurate Intraday Trading Signals - newser.com
Building trade automation scripts for Grace Therapeutics Inc.2025 Institutional Moves & Growth Focused Stock Pick Reports - newser.com
Is this a good reentry point in Grace Therapeutics Inc.Gap Up & Low Risk Entry Point Guides - newser.com
Published on: 2025-11-02 05:34:07 - newser.com
Is Grace Therapeutics Inc. stock attractive for growth ETFsProfit Target & AI Based Trade Execution Alerts - newser.com
Grace Therapeutics, Inc. (GRCE) Analyst insights, Price targets and Recommendations - Yahoo! Finance Australia
Grace Therapeutics, Inc. (GRCE) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Published on: 2025-11-01 12:11:05 - newser.com
This Grace Therapeutics Insider Increased Their Holding By 12% Last Year - Yahoo Finance
Why Grace Therapeutics Inc. stock is in analyst buy zone2025 Earnings Surprises & Stock Portfolio Risk Control - newser.com
Grace Therapeutics Inc Azioni (GRCE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):